MGNX vs SPGI · rev $39.6M vs P/E 27, rev $15.34B
MacroGenics Inc (MGNX) versus S&P Global Inc (SPGI) — a side-by-side from cached financials, not a winner call.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Latest reported MGNX revenue for 2026-06-30 was $39.6M. Net income was -$17.3M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. MGNX currently screens at market cap $246.6M.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
MGNX currently screens at market cap $246.6M. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Not investment advice. Open the MGNX and SPGI stock pages for the full models.
Not investment advice.